Related Experiment Video
Updated: Oct 17, 2025

A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats
Published on: May 22, 2019
Antidepressant use and stroke or mortality risk in the elderly
Begüm Irmak Ön1, Xavier Vidal2, Ursula Berger1
1Institute for Medical Information Processing, Biometry and Epidemiology, LMU Munich, Munich, Germany.
Elderly antidepressant use is linked to higher stroke and mortality risks, especially for recent and past users. Current users face increased stroke risk but decreased mortality. Careful consideration of risks is advised.
Area of Science:
- Geriatric Medicine
- Pharmacology
- Epidemiology
Background:
- Evidence on antidepressant risks for stroke and mortality is inconsistent.
- The elderly population has the highest exposure to antidepressants.
- This study addresses the need to quantify risks in this vulnerable group.
Purpose of the Study:
- To evaluate the association between antidepressant use and risks of stroke and mortality in individuals aged 65 and older.
- To analyze these risks across different patterns of antidepressant exposure: current, recent, and past use.
Main Methods:
- A cohort study included over 1 million individuals aged 65+ from Catalonia (2010-2015).
- Antidepressant exposure was categorized into current, recent, past users, and non-users (controls).
- Cox regression analysis, adjusted for risk factors, assessed the combined risk of stroke or death.
Main Results:
- Antidepressant use was associated with higher risks of stroke or death for current (HR 1.04), recent (HR 3.34), and past users (HR 2.06).
- Current antidepressant use showed increased stroke risk (HR 1.56) but decreased mortality risk (HR 0.93).
- Recent and past use were linked to significantly increased risks for both stroke and mortality.
Conclusions:
- Antidepressant use in the elderly may elevate stroke risk.
- Potential risks associated with antidepressant use in older adults warrant careful consideration.
More Related Videos
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
04:33Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Drug Dosing: Geriatric Patients
Pharmacodynamics in Geriatric Patients: Effects of Age
Antidepressant Drugs: Overview
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism